Cargando…
The make or buy debate: Considering the limitations of domestic production in Tanzania
BACKGROUND: In order to ensure their population’s regular access to essential medicines, many least developed countries and developing countries are faced with the policy question of whether to import or manufacture drugs locally, in particular for life-saving antiretroviral medicines for HIV/AIDS p...
Autores principales: | Wilson, Kinsley Rose, Kohler, Jillian Clare, Ovtcharenko, Natalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413540/ https://www.ncbi.nlm.nih.gov/pubmed/22747578 http://dx.doi.org/10.1186/1744-8603-8-20 |
Ejemplares similares
-
Why the MDGs need good governance in pharmaceutical systems to promote global health
por: Kohler, Jillian Clare, et al.
Publicado: (2014) -
Corporate social responsibility to improve access to medicines: the case of Brazil
por: Thorsteinsdóttir, Halla, et al.
Publicado: (2017) -
An examination of pharmaceutical systems in severely disrupted countries
por: Kohler, Jillian Clare, et al.
Publicado: (2012) -
The Past, Present and Future of Domestic Equines in Tanzania
por: WILSON, R. Trevor
Publicado: (2013) -
Prevention of non-communicable disease: best buys, wasted buys, and contestable buys
por: Isaranuwatchai, Wanrudee, et al.
Publicado: (2020)